NOVEL DRUGS RECENTLY AUTHORIZED BY EMA AND FDA (Q3, 2022)

Rodriguez, S. C.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

NOVEL DRUGS RECENTLY AUTHORIZED BY EMA AND FDA (Q3, 2022)

Rodriguez, S. C..

Anales de la Real Academia Nacional de Farmacia ; 88(3):323-335, 2022.

Article in Spanish | EMBASE | ID: covidwho-2172099

Keywords

amyloidosis/dt [Drug Therapy]; article; drug approval; European Medicines Agency; Food and Drug Administration; neutropenia/dt [Drug Therapy]; psoriasis/dt [Drug Therapy]; asciminib/pe [Pharmacoeconomics]; avalglucosidase alfa/pe [Pharmacoeconom

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: EMBASE Language: Spanish Journal: Anales de la Real Academia Nacional de Farmacia Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: EMBASE Language: Spanish Journal: Anales de la Real Academia Nacional de Farmacia Year: 2022 Document Type: Article